clopidogrel has been researched along with Liver Dysfunction in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cuschieri, JR; Drawz, P; Falck-Ytter, Y; Wong, RC | 1 |
Goyal, RK; Lessnau, KD; Srivastava, D | 1 |
Guidotti, LG; Iannacone, M; Narvaiza, I; Ruggeri, ZM; Sitia, G | 1 |
Carson, JJ; Zeolla, MM | 1 |
1 review(s) available for clopidogrel and Liver Dysfunction
Article | Year |
---|---|
Clopidogrel-induced hepatocellular injury and cholestatic jaundice in an elderly patient: case report and review of the literature.
Topics: Aged; Angioplasty, Balloon, Coronary; Chemical and Drug Induced Liver Injury; Clinical Enzyme Tests; Clopidogrel; Female; Humans; Jaundice, Obstructive; Liver Diseases; Platelet Aggregation Inhibitors; Ticlopidine | 2009 |
3 other study(ies) available for clopidogrel and Liver Dysfunction
Article | Year |
---|---|
Risk factors for acute gastrointestinal bleeding following myocardial infarction in veteran patients who are prescribed clopidogrel.
Topics: Acute Disease; Age Factors; Aged; Anticoagulants; Chronic Disease; Clopidogrel; Female; Gastrointestinal Hemorrhage; Humans; Kaplan-Meier Estimate; Kidney Diseases; Liver Diseases; Male; Middle Aged; Myocardial Infarction; Ohio; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Assessment; Risk Factors; Ticlopidine; Veterans; Warfarin | 2014 |
Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus.
Topics: Adenoviridae; Adenoviridae Infections; Animals; Aspirin; Clopidogrel; Defective Viruses; Immune System Diseases; Leukocytes; Liver; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Platelet Aggregation Inhibitors; T-Lymphocytes, Cytotoxic; Ticlopidine | 2007 |
Successful use of clopidogrel for cerebrovascular accident in a patient with suspected ticlopidine-induced hepatotoxicity.
Topics: Aged; Cerebrovascular Disorders; Chemical and Drug Induced Liver Injury; Clopidogrel; Female; Humans; Liver Diseases; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome | 1999 |